Our data implicate FLNA downstream of CaSR as possible regulator of MLL-AF9+ AML and suggest possible CaSR-mediated effects on intracellular calcium levels, which may contribute to our observations in MLL-AF9+ AML. The gene discussed is CASR; the disease is acute myeloid leukemia.